Faeth Therapeutics (FTH) Reiterated at Overweight by Cantor Fitzgerald After Investor Day

October 7, 2026 6:50 AM

Cantor Fitzgerald analyst Li Watsek reiterated an Overweight rating on Faeth Therapeutics (NASDAQ: FTH).The analyst commented, "Faeth’s inaugural investor/analyst day ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found